Status:
UNKNOWN
Bone Metastases in neurOendocrine NEoplasms: naTural History, Prognostic Impact and Therapeutic Approach (MONET)
Lead Sponsor:
European Institute of Oncology
Conditions:
Bone Metastases
Neuroendocrine Neoplasm
Eligibility:
All Genders
Brief Summary
This is a retrospective/prospective observational multicentric trial on patients with bone metastases from NENs. General objectives: * To trace on a national scale the frequency of bone metastases i...
Detailed Description
Background, rationale and objectives: On March 25th 2015 the Ethical Committee from IEO approved the academic study entitled "Bone metastases in neuroendocrine tumors (NETs): a survey on natural hist...
Eligibility Criteria
Inclusion
- Histological diagnosis of NEN
- Instrumental and/or histological diagnosis of bone metastasis
- At least one year of follow-up from the diagnosis of bone metastasis
Exclusion
- Small cell lung carcinoma
- MiNEN
- Non neuroendocrine neoplasm
Key Trial Info
Start Date :
January 8 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04720391
Start Date
January 8 2021
End Date
December 31 2021
Last Update
January 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
European Institute of Oncology, IEO, IRCCS
Milan, Italy, 20141